NXTC's logo.
Ticker Symbol: NXTC

Nextcure Inc

$6.05 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001661059

Company Profile

NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through its proprietary FIND-IO™ platform, NextCure studies various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. Its initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 9000 Virginia Manor Rd Ste 200
CEO: Michael Richman
Tags:
  • Biotechnology
  • Health Technology

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.32
Change: $0.04 ( 3.12%)
Days Range: $1.23 - $1.34
Beta: 0.82
52wk. High: $2.66
52wk. Low: $1.15
Ytd. Change -6.09%
50 Day Moving Average: $1.34
200 Day Moving Average: $1.58
Shares Outstanding: 27839968

Valuation

Market Cap: 3.7B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A